(Q43581433)

24 November 2017

title

Estimating the consequences of anti-psychotic induced weight gain on health and mortality rate (English)

1 reference

24 November 2017

1 reference

1 reference

7

1 reference

24 November 2017

Fontaine KR

1

1 reference

24 November 2017

Heo M

2

1 reference

24 November 2017

Harrigan EP

3

1 reference

24 November 2017

Shear CL

4

1 reference

24 November 2017

Lakshminarayanan M

5

1 reference

24 November 2017

Casey DE

6

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

24 November 2017

1 reference

24 November 2017

volume

101

1 reference

24 November 2017

issue

3

1 reference

24 November 2017

page(s)

277-288

1 reference

Obesity treatment: examining the premises

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900234-7

7 January 2021

Annual Deaths Attributable to Obesity in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900234-7

7 January 2021

The distribution of body mass index among individuals with and without schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900234-7

7 January 2021

Causes of the excess mortality of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900234-7

7 January 2021

Will the new antipsychotics bring hope of reducing the risk of developing extrapyramidal syndromes and tardive dyskinesia?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900234-7

7 January 2021

Prescription medications: a modifiable contributor to obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900234-7

7 January 2021

Epidemiological approaches to heart disease: the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900234-7

7 January 2021

Mental disorders and use of cardiovascular procedures after myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900234-7

7 January 2021

Olanzapine for schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900234-7

7 January 2021

Overweight and obesity in the United States: prevalence and trends, 1960-1994

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900234-7

7 January 2021

Clozapine and body mass change.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900234-7

7 January 2021

Prospective study of intentionality of weight loss and mortality in older women: the Iowa Women's Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900234-7

7 January 2021

Excess mortality of mental disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900234-7

7 January 2021

Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900234-7

7 January 2021

The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900234-7

7 January 2021

Swedish obese subjects (SOS): an obesity intervention study with a nutritional perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900234-7

7 January 2021

Body Weight and Mortality among Women

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900234-7

7 January 2021

Mortality in a cohort of patients with schizophrenia: a record linkage study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900234-7

7 January 2021

Time trends in schizophrenia mortality in Stockholm county, Sweden: cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900234-7

7 January 2021

A review of long-term studies evaluating the efficacy of weight loss in ameliorating disorders associated with obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900234-7

7 January 2021

The treatment of unrelated disorders in patients with chronic medical diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900234-7

7 January 2021

Suicide prevention effects associated with clozapine therapy in schizophrenia and schizoaffective disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900234-7

7 January 2021

The distribution of adipose tissue in female in-patients receiving psychotropic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900234-7

7 January 2021

Newer atypical antipsychotic medication versus clozapine for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900234-7

7 January 2021

Clozapine versus typical neuroleptic medication for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900234-7

7 January 2021

Report of a National Institutes of Health--Centers for Disease Control and Prevention workshop on the feasibility of conducting a randomized clinical trial to estimate the long-term health effects of intentional weight loss in obese persons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900234-7

7 January 2021

10.1016/S0165-1781(01)00234-7

Identifiers

DOI

1 reference

24 November 2017

1 reference